Chapter 1 Preface
1.1 Report Description
1.1.1 Purpose of the Report
1.1.2 Target Audience
1.1.3 USP and Key Offerings
1.2 Research Scope
1.3 Research Methodology
1.3.1 Phase I – Secondary Research
1.3.2 Phase II – Primary Research
1.3.3 Phase III – Expert Panel Review
1.3.4 Assumptions
Chapter 2 Executive Summary
Chapter 3 Tamoxifen: Market Dynamics and Outlook
3.1 Introduction
3.2 Breast Cancer: Key Statistics
3.3 Major Events Assessment
3.4 Market Dynamics
3.4.1 Drivers
3.4.1.1 Advantages of Hormone Therapy Across Different Stages of Treatment
3.4.1.2 Widespread use as Adjuvant and Neo-Adjuvant Therapy
3.4.2 Challenges
3.4.2.1 Growth in Tamoxifen-Resistant Breast Cancer
3.4.3 Opportunities
3.4.3.1 Alternative uses of Tamoxifen
3.5 Attractive Investment Proposition
3.6 Market Positioning of Key Manufacturers
Chapter 4 Global Tamoxifen Market, Pipeline Analysis
4.1 Preface
4.2 Phase III
4.3 Phase II
4.4 Phase I
Chapter 5 Global Tamoxifen Market, by Geography
5.1 Introduction
5.2 North America
5.2.1 U.S.
5.2.2 Canada
5.3 Europe
5.3.1 United Kingdom
5.3.2 Germany
5.3.3 Rest of Europe
5.4 Asia-Pacific
5.4.1 China
5.4.2 Japan
5.4.3 Rest of Asia-Pacific
5.5 Rest of the World
Chapter 6 Company Profiles
6.1 Astra Zeneca plc
6.1.1 Astra Zeneca plc: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Key Industries Served, SCOT Analysis, Recent Developments)
6.2 Teva Pharmaceutical Industries Ltd.
6.2.1 Teva Pharmaceutical Industries Ltd.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Key Industries Served, SCOT Analysis, Recent Developments)
6.3 Allergen plc
6.3.1 Allergen plc: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Key Industries Served, SCOT Analysis, Recent Developments)
6.4 Mylan Pharmaceuticals, Inc.
6.4.1 Mylan Pharmaceuticals, Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Key Industries Served, SCOT Analysis, Recent Developments)
6.5 Apotex, Inc
6.5.1 Apotex, Inc: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Key Industries Served, SCOT Analysis, Recent Developments)
List of Figures
FIG. 1 Global Tamoxifen Market: Research Methodology
FIG. 2 Global Tamoxifen Market, by Geography, 2015 (US$ Mn)
FIG. 3 Attractive Investment Proposition: Global Tamoxifen Market, by Geography, 2015
FIG. 4 Market Positioning of Key Manufacturers in Tamoxifen Market, 2015 (Value %)
FIG. 5 U.S. Tamoxifen Market, 2013 – 2022 (US$ Mn)
FIG. 6 Canada Tamoxifen Market, 2013 – 2022 (US$ Mn)
FIG. 7 European Age-Standardized Mortality Rates per 100,000 Population, Females, U.K.
FIG. 8 United Kingdom Tamoxifen Market, 2013 – 2022, (US$ Mn)
FIG. 9 Germany Tamoxifen Market, 2013 – 2022, (US$ Mn)
FIG. 10 Rest of Europe Tamoxifen Market, 2013 – 2022, (US$ Mn)
FIG. 11 China Tamoxifen Market Revenue, 2015 – 2022 (US$ Mn)
FIG. 12 Japan Tamoxifen Market, 2013– 2022 (US$ Mn)
FIG. 13 Rest of Asia-Pacific Tamoxifen Market, 2013 – 2022 (US$ Mn)
List of Tables
TABLE 1 Global Tamoxifen Market Revenue, 2015 Vs 2022 (US$ Mn)
TABLE 2 National Statistics: Breast Cancer Incidence Rate for Key Countries, 2012
TABLE 3 North America Tamoxifen Market, by Country, 2013-2022 (US$ Mn)
TABLE 4 Estimated New Female Breast Cancer Cases and Deaths by Age, U.S., 2013
TABLE 5 Canada Breast Cancer Statistics, 2015
TABLE 6 Europe Tamoxifen Market, 2013–2022, (US$ Mn)
TABLE 7 Breast Cancer Incidence Rate and Mortality Rate in Germany, 2012
TABLE 8 Breast Cancer Incidence Rate in Rest of European Countries, 2012
TABLE 9 Breast Cancer Survivors Post Diagnosis in Rest of European Countries, 2012
TABLE 10 Asia-Pacific Tamoxifen Market, 2013-2022 (US$ Mn)
TABLE 11 Rest of the World Tamoxifen Market, by Region, 2013-2022
TABLE 12 Astra Zeneca plc: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Key Industries Served, SCOT Analysis, Recent Developments)
TABLE 13 Teva Pharmaceutical Industries Ltd.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Key Industries Served, SCOT Analysis, Recent Developments)
TABLE 14 Allergen plc: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Key Industries Served, SCOT Analysis, Recent Developments)
TABLE 15 Mylan Pharmaceuticals, Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Key Industries Served, SCOT Analysis, Recent Developments)
TABLE 16 Apotex, Inc: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Key Industries Served, SCOT Analysis, Recent Developments)